Molten first invested in Freetrade in the Series A in 2019. This deal values Molten's stake 30% above the 30 September 2024 holding value of £17 million and will deliver a 1.6x multiple on invested ...
ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty biologics, today ...